title: Use of available outer membrane vesicle vaccines to control serogroup B meningococcal outbreaks.
authors.forename: Muhamed-Kheir
authors.initials: MK
authors.lastname: Taha
authors.forename: Maria Leticia
authors.initials: ML
authors.lastname: Zarantonelli
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Alonso
authors.forename: Lisbeth Meyer
authors.initials: LM
authors.lastname: Naess
authors.forename: Johan
authors.initials: J
authors.lastname: Holst
authors.forename: Berit
authors.initials: B
authors.lastname: Feiring
authors.forename: Einar
authors.initials: E
authors.lastname: Rosenqvist
mesh_terms: D001425:Bacterial Outer Membrane Proteins / Q000276:immunology*; D001770:Blood Bactericidal Activity; D004196:Disease Outbreaks; D006801:Humans; D008589:Meningococcal Infections / Q000453:epidemiology / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000276:immunology*; D038541:Neisseria meningitidis, Serogroup B / Q000276:immunology*
chemical_list: D001425:Bacterial Outer Membrane Proteins; D022401:Meningococcal Vaccines